Tirisham Gyang, MD

Assistant  Professor of Neurology

Phone: (352) 273-5550
Fax: (352) 273-5575

Department of Neurology

Room L3-100, McKnight Brain Institute
1149 Newell Drive
Gainesville, FL. 32611

 

Tirisham Gyang M.D, is a neurologist specialized in multiple sclerosis and neuroimmunology. She completed he undergraduate studies at Saint Louis University, St Louis MO and then attended the global scholar’s program of St Georges University Medical School. During medical school she developed an interest in neurology and eventually completed her neurology residency at SUNY Upstate Medical University in Syracuse NY. This led to a more specific interest in multiple sclerosis and similar disorders.

 

Awards and Recognition

2015 Resident Professionalism Award, Neurology Department SUNY Upstate
2015 CMSC Mentorship scholarship
2014 Resident Scholarship Award, Neurology Department SUNY Upstate
2014 National Doctors Day Award, Upstate University Hospital
2013 New York State Neurological Society, New York State 2013 Neurostake winner – delegate member

Professional Societies Affiliations

American Academy of Neurology, 2012 – Present
Consortium of Multiple Sclerosis Centers (CMSC), 2015- Present
MS Professionals in training MSPiT – CMSC, 2015- Present

Medical Education

Keith B. Taylor Global scholars program, St George’s University School of Medicine, Grenada, West Indies – 2010

Internship

 Internal Medicine, SUNY Upstate Medical University, Syracuse, NY – 2012

Residency

Neurology Resident, SUNY Upstate Medical University, Syracuse, NY – 2015

Fellowships

Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY – 2017
Neuroimmunology and Multiple sclerosis; National Multiple Sclerosis Society (NMSS) Scholar, University of Rochester Medical Center, Rochester, NY – 2017

Publications

Gyang T, Hammel J, Goodman A, Gross, R, Samkoff L. Fingolimod-associated PML in a patient with prior immunosuppression. Neurology May 10, 2016 vol. 86 no. 19 1843-1845.

Goodman A, Gyang T, Smith A. Ibudilast for the treatment of multiple sclerosis. Expert Opinion Investig Drugs. 2016 Oct;25(10):1231-7.